144 related articles for article (PubMed ID: 6149575)
1. Structure and activation of complement components C2 and factor B.
Gagnon J
Philos Trans R Soc Lond B Biol Sci; 1984 Sep; 306(1129):301-9. PubMed ID: 6149575
[TBL] [Abstract][Full Text] [Related]
2. Partial sequence of human complement component factor B: novel type of serine protease.
Christie DL; Gagnon J; Porter RR
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4923-7. PubMed ID: 6776529
[TBL] [Abstract][Full Text] [Related]
3. Human complement proteins D, C2, and B. Active site mapping with peptide thioester substrates.
Kam CM; McRae BJ; Harper JW; Niemann MA; Volanakis JE; Powers JC
J Biol Chem; 1987 Mar; 262(8):3444-51. PubMed ID: 3546307
[TBL] [Abstract][Full Text] [Related]
4. The functional inhibition of activated C1 inhibitor in normal human serum causes spontaneous consumption of the complement components C2, C3, C4, and factor B.
Gronski P; Bodenbender L; Kanzy EJ; Piepenbrock M; Seiler FR
Immunobiology; 1986 Apr; 171(3):252-62. PubMed ID: 3011651
[TBL] [Abstract][Full Text] [Related]
5. The proteolytic activation systems of complement.
Reid KB; Porter RR
Annu Rev Biochem; 1981; 50():433-64. PubMed ID: 7023363
[No Abstract] [Full Text] [Related]
6. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
7. MASP-2, the C3 convertase generating protease of the MBLectin complement activating pathway.
Vorup-Jensen T; Jensenius JC; Thiel S
Immunobiology; 1998 Aug; 199(2):348-57. PubMed ID: 9777418
[TBL] [Abstract][Full Text] [Related]
8. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
9. Amino acid sequence of the Bb fragment from complement Factor B. Sequence of the major cyanogen bromide-cleavage peptide (CB-II) and completion of the sequence of the Bb fragment.
Christie DL; Gagnon J
Biochem J; 1983 Jan; 209(1):61-70. PubMed ID: 6342610
[TBL] [Abstract][Full Text] [Related]
10. The reaction of iodine and thiol-blocking reagents with human complement components C2 and factor B. Purification and N-terminal amino acid sequence of a peptide from C2a containing a free thiol group.
Parkes C; Gagnon J; Kerr MA
Biochem J; 1983 Jul; 213(1):201-9. PubMed ID: 6555044
[TBL] [Abstract][Full Text] [Related]
11. C3 nephritic factor stabilization of the classic C3 convertase: a role for C2 in C3 nephritic factor activity.
McLean RH; Nilson SH
Proc Soc Exp Biol Med; 1979 Jul; 161(3):358-63. PubMed ID: 461464
[No Abstract] [Full Text] [Related]
12. The factor B and C2 genes.
Campbell RD; Bentley DR; Morley BJ
Philos Trans R Soc Lond B Biol Sci; 1984 Sep; 306(1129):367-78. PubMed ID: 6149579
[TBL] [Abstract][Full Text] [Related]
13. Structural evidence that complement factor B constitutes a novel class of serine protease.
Mole JE; Niemann MA
J Biol Chem; 1980 Sep; 255(18):8472-6. PubMed ID: 6997298
[TBL] [Abstract][Full Text] [Related]
14. Activation of factor B of the complement system by kallikrein and its light chain.
Hiemstra PS; Daha MR; Bouma BN
Thromb Res; 1985 Jun; 38(5):491-503. PubMed ID: 3848216
[TBL] [Abstract][Full Text] [Related]
15. Structural biology of the alternative pathway convertase.
Xu Y; Narayana SV; Volanakis JE
Immunol Rev; 2001 Apr; 180():123-35. PubMed ID: 11414354
[TBL] [Abstract][Full Text] [Related]
16. A conserved element in the serine protease domain of complement factor B.
Hourcade DE; Mitchell LM; Oglesby TJ
J Biol Chem; 1998 Oct; 273(40):25996-6000. PubMed ID: 9748277
[TBL] [Abstract][Full Text] [Related]
17. C2 by-pass: Cross-talk between the complement classical and alternative pathways.
Laich A; Patel H; Zarantonello A; Sim RB; Inal JM
Immunobiology; 2022 May; 227(3):152225. PubMed ID: 35567980
[TBL] [Abstract][Full Text] [Related]
18. The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.
Krishnan V; Xu Y; Macon K; Volanakis JE; Narayana SV
Acta Crystallogr D Biol Crystallogr; 2009 Mar; 65(Pt 3):266-74. PubMed ID: 19237749
[TBL] [Abstract][Full Text] [Related]
19. Amino acid sequence of the Bb fragment from human complement Factor B. Alignment of the cyanogen bromide-cleavage peptides.
Gagnon J; Christie DL
Biochem J; 1983 Jan; 209(1):51-60. PubMed ID: 6342609
[TBL] [Abstract][Full Text] [Related]
20. The biochemistry of complement.
Porter RR; Reid KB
Nature; 1978 Oct; 275(5682):699-704. PubMed ID: 703835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
